Opinion

Video

Acalabrutinib-Based Treatment Clinical Trial Updates

Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Related Content
Among patients with CLL, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections: © stock.adobe.com.
August 23rd 2025

Immunoglobulin Replacement Not Associated With Fewer Infections in CLL

Alex Biese
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
August 23rd 2025

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
Jaypirca led to better response rates than Imbruvica in some previously treated patients with CLL/SLL: © stock.adobe.com.
August 23rd 2025

Jaypirca Shows Improvements Over Imbruvica in CLL/SLL

Spencer Feldman
CURE Talks Cancer podcast
August 23rd 2025

The Treatment Journey of a Patient with CLL

Kristie L. Kahl
fda sign.
August 23rd 2025

Therapies Which Received FDA Approval in June: What You Should Know

Ryan Scott
Linda Cohen is a survivor of small lymphocytic lymphoma and was diagnosed in 2009. Catch up on all of Linda's blogs here!
August 23rd 2025

A Cocktail and the Freedom I Never Expected With Cancer

Linda Cohen